Based on our previous data17 and the HSF1 knockdown study, we hypothesized that the inhibition of heat shock response (HSR) by KRIBB11, a specific inhibitor of HSF157, could potentiate the anticancer effects of mEHTin tumor allografts. This evidence concerns the gene HSF1 and neoplasm.